0001599901EX-FILING FEESfalsefalseCommon Stock, $0.0001 par valueCommon Stock, $0.0001 par value0.000147600.00014760 0001599901 2024-08-09 2024-08-09 0001599901 1 2024-08-09 2024-08-09 0001599901 2 2024-08-09 2024-08-09 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
CALCULATION OF FILING FEE TABLE
Form
S-8
(Form Type)
Avidity Biosciences, Inc.
(Exact name of registrant as specified in its charter)
Table 1: Newly Registered Securities
 
Security 
Type 
 
 Security  
Class 
Title 
 
Fee
 Calculation  
Rule
 
Amount
 Registered  
(1)
 
Proposed 
Maximum 
Offering 
Price Per 
Share 
 
Maximum 
Aggregate 
 Offering Price  
 
Fee Rate
 
Amount of 
Registration 
Fee 
Equity
 
Common
Stock,
$0.0001
par value
  Rule 457(c)
and Rule
457(h)
  3,000,000
(2)
  $39.70 (3)   $119,100,000.00
(3)
  $
147.60
 per $1,000,000 
  $17,579.16
   
Common
Stock,
$0.0001
par value
  Rule 457(c)
and Rule
457(h)
  288,200 (4)   $44.81 (5)   $12,914,242.00   $
147.60
 per $1,000,000 
  $1,906.15
Total Offering Amounts
      $132,014,242.00       $19,485.30
Total Fee Offsets (6)
              $0
Net Fee Due
              $19,485.30
 
  (1)
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also registers an indeterminate number of additional shares that may be issued pursuant to the above-named plans as the result of any future stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of our outstanding shares of common stock.
 
  (2)
Represents 3,000,000 shares of common stock available for fu
tur
e issuance under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the “Inducement Plan”).
 
  (3)
This estimate is made pursuant to Rule 457(c) and 457(h) of the Securities Act solely for purposes of calculating the registration fee. The maximum offering price per share and the maximum aggregate offering price are based upon the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Global Select Market on August 5, 2024, which date is within five business days prior to filing this registration statement.
 
  (4)
Consists of 288,200 shares of common stock subject to outstanding stock options under the Inducement Plan. To the extent that outstanding stock options or other awards under the Inducement Plan are forfeited or lapse unexercised, the shares of common stock subject to such awards will be available for future issuance under the Inducement Plan.
 
  (5)
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) of the Securities Act, and based upon the weighted average exercise price of the outstanding stock options granted under the Inducement Plan.
 
  (6)
The Registrant does not have any fee offsets.